摘要
目的探讨抗幽门螺杆菌(HP)感染在缺铁性贫血(IDA)治疗中的临床价值。方法将伴有HP阳性慢性胃炎的IDA患者116例随机分成A、B两组,A组给予铁剂联合HP根除治疗;B组仅予补铁治疗。观察两组患者治疗前后红蛋白(Hb)、血清铁(SI)、血清铁蛋白(SF)等血液学指标的变化。结果 A组的治疗效果明显优于B组,差异有统计学意义(P<0.05)。结论抗HP加铁剂是治疗HP感染相关性IDA的有效方法,具有重要临床价值。
Objective To explore the clinical value of the anti-Helicobacter pylori（HP） infection in treatment for iron deficiency anemia（IDA）.Methods116 cases of IDA with HP-positive chronic gastritis were randomly divided into A,B group.A group was treated with HP eradication therapy combined iron and B group only with iron therapy.Hemoglobin（Hb）,serum iron（SI）,serum ferritin（SF） and other hematological indexes were observed before and after treatment in patients with treatments.ResultsIron therapy combined with anti HP treatment was better than pure iron in treatment for IDA.The difference between the two groups was statistically significant（P〈0.05）.ConclusionThe anti-HP treatment of HP infection plus iron is an effective method of IDA.
出处
《西部医学》
2011年第4期666-667,共2页
Medical Journal of West China
关键词
幽门螺杆菌
缺铁性贫血
治疗
Helicobacter pylori
Iron deficiency anemia
Treatment
